Healthcare -
Biotechnology - NASDAQ - US
$ 26.33
-8.8 %
$ 2.96 B
Market Cap
-26.07
P/E
VKTX - OTHER ACCUMULATIVE COMPREHENSIVE INCOME LOSS
Other Accumulative Comprehensive Income Loss VKTX - Viking Therapeutics, Inc.
-389 K
LAST VALUE
15.82%
2 YEAR CAGR
1.66%
5 YEAR CAGR
-56.21%
10 YEAR CAGR